Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
d-cycloserine augmentation of exposure therapy for child anxiety
ACTRN12611000660987Phase 4Completed
- Sponsor
- Macquarie University
- Start
- Aug 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder and specific phobia comparing d-cycloserine + in-vivo exposure with placebo + in-vivo exposure (2 arms). Primary endpoint: Anxiety and avoidance of key fear. Started Aug 2011; status: completed.
02
Drugs
d-cycloserine
03
Conditions
anxiety disorderspecific phobia
Beyond the preview
Go deeper on ACTRN12611000660987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000660987.